SAREPTA THERAPEUTICS, INC. Inventory, Raw Materials, Net of Reserves
SAREPTA THERAPEUTICS, INC. (SRPT) had Inventory, Raw Materials, Net of Reserves of $127.78 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2026-08-05
- 2026-06-30: Inventory, Raw Materials, Net of Reserves $127.78M.
- 2026-03-31: Inventory, Raw Materials, Net of Reserves $136.96M.
- 2025-12-31: Inventory, Raw Materials, Net of Reserves $141.28M.
- 2025-09-30: Inventory, Raw Materials, Net of Reserves $325.54M.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2026-06-30 | $127.78M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $136.96M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $141.28M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $325.54M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $314.85M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $298.98M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $280.05M 10-K · filed 2026-03-02 |
| 2024-09-30 | $208.32M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $167.20M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $150.01M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $133.96M 10-K · filed 2025-02-28 |
| 2023-09-30 | $114.62M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $102.84M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $84.47M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $59.18M 10-K · filed 2024-02-28 |
| 2022-09-30 | $57.98M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $42.40M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $41.27M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $58.82M 10-K · filed 2023-02-28 |
| 2021-09-30 | $40.16M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $47.77M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $62.24M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $71.72M 10-K · filed 2022-03-01 |
| 2020-09-30 | $80.14M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $75.98M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $81.74M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $82.03M 10-K · filed 2021-03-01 |
| 2019-09-30 | $74.08M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $72.13M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $70.27M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $71.31M 10-K · filed 2020-02-26 |
| 2018-09-30 | $68.69M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $64.53M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $63.49M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $53.88M 10-K · filed 2019-02-28 |
| 2017-09-30 | $44.26M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $27.81M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $24.90M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $9.53M 10-K · filed 2018-03-01 |
| 2016-09-30 | $2.71M 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |